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Abstract: Mutant mice with respect to the splicing factor Zrsr1 present altered spermatogenesis and
infertility. To investigate whether Zrsr1 is involved in the homeostatic control that the hypothalamus
exerts over reproductive functions, we first analyzed both differential gene and isoform expression
and alternative splicing alterations in Zrsr1 mutant (Zrsr1mu) hypothalamus; second, we analyzed
the spontaneous and social behavior of Zrsr1mu mice; and third, we analyzed adult cell proliferation
and survival in the Zrsr1mu hypothalamus. The Zrsr1mu hypothalamus showed altered expression of
genes and isoforms related to the glutathione metabolic process, synaptonemal complex assembly,
mRNA transport, and altered splicing events involving the enrichment of U12-type intron retention
(IR). Furthermore, increased IR in U12-containing genes related with the prolactin, progesterone,
and gonadotropin-releasing hormone (GnRH) reproductive signaling pathway was observed. This was
associated with a hyperactive phenotype in both males and females, with an anxious phenotype
in females, and with increased social interaction in males, instead of the classical aggressive
behavior. In addition, Zrsr1mu females but not males exhibited reduced cell proliferation in both the
hypothalamus and the subventricular zone. Overall, these results suggest that Zrsr1 expression and
function are relevant to organization of the hypothalamic cell network controlling behavior.
Keywords: Zrsr1; U12 introns; hypothalamus; behavior; social interaction; neurogenesis; cell proliferation
1. Introduction
The paralogous splicing factors ZRSR1 (also known as U2af1-rs1) and ZRSR2 (also known as
U2af1-rs2), encoded by the Zrsr1 and Zrsr2 genes, have been identified in all mammalian species
analyzed [1,2] and are known to recognize the 3′AG splice site of the intron. They have been attributed
an essential role in splice site recognition of U12 minor introns [3]. Minor class or U12-dependent
spliceosomes remove U12-type introns (<0.4% of all introns) [4], which are non-randomly distributed
across the genome and, despite their scarce abundance, are highly conserved across distantly related
Int. J. Mol. Sci. 2019, 20, 3543; doi:10.3390/ijms20143543 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2019, 20, 3543 2 of 18
eukaryotic taxa, indicating their evolutionary origin. MurineZrsr1 is a retrotransposed copy of X-linked
Zrsr2 (located on the X chromosome in all mammalian species analyzed). Zrsr1 is located within an
intron of Commd1 and is paternally expressed in the placenta and some adult tissues, while the maternal
copy is methylated and silent. Zrsr1 knockout mice do not show an abnormal phenotype [5], probably
because of the expression of the other paralog. However, we recently demonstrated that Zrsr1 plays
critical roles in hematopoiesis, muscle strength, and spermatogenesis in mice. Zrsr1 mutation produced
critical alterations at the spermatocyte stage, affecting U12 introns [1]. In contrast, female mice with
mutant Zrsr1 do not show any effect in the female estrous cycle; they are normal cyclin females and
respond to superovulation like control females [1]. Zrsr1 expression has been reported in neonatal and
adult mouse brain [1,6], with the hypothalamus being the area with greatest expression (BIOGPX.org:
http://ds.biogps.org/?gene=22183). Extensive genetic regulation of transcription and alternative splicing
have been reported in the hypothalamus, and a considerable proportion of the new isoforms and
transcripts are significantly correlated to physiological phenotypes [7]. Since the hypothalamus plays
a key role in male reproductive control, in the present study we analyzed the alterations in gene
expression and RNA alternative splicing in the Zrsr1 mutant (Zrsr1mu) hypothalamus.
Genes containing U12 introns are over-represented in functions and pathways related to
development, such as RNA processing, DNA replication, cell cycle, MAPK signaling, voltage-gated ion
channels, signal transduction, and DNA damage repair [8,9]. Dysregulation of the minor spliceosome
generally leads to intron retention and, less frequently, to exon skipping [10] and has been associated
with multiple diseases, including developmental disorders [1,8,11–13], neurodegeneration [14],
and cancer [15]. These diseases can be caused by mutations within both the protein and small
nuclear ribonucleic acid (snRNA) components of the minor spliceosome. In addition, the minor
spliceosome is thought to play an important developmental role in plants [16,17], Drosophila [18],
and zebrafish [19] and in the mouse central nervous system [20]. However, the specific roles of minor
splicing on the hypothalamus have not been fully elucidated. In relation with the enrichment of
U12 genes related to ion channels, it is important to indicate that ion channels play essential roles in
various cellular functions in the nervous system [21], and alternative splicing of ion channels induces
changes in their cellular distribution, activation/inactivation kinetics, voltage/Ca2+ dependence,
and pharmacological drug sensitivities [22].
To examine the role of the ZRSR1 minor splicing factor in the hypothalamus, we analyzed
differential gene and isoform expression and alterations in alternative splicing in the Zrsr1mu
hypothalamus. Furthermore, we analyzed the serum testosterone levels and social behavior of
Zrsr1mu mice, and we have quantified cell proliferation and survival in the Zrsr1mu hypothalamus and
subventricular zone, a major adult neurogenesis niche in rodents. Collectively, this study identifies
Zrsr1 as an essential factor for efficient U12 intron splicing in the hypothalamus, critical for the
organization of hypothalamic cell networks that organize behavior.
2. Results
2.1. Expression of ZRSR1mu in the Hypothalamus
In order to verify the effective mutation of ZRSR1 in the hypothalamus, we conducted Western blot
in wild-type (WT) and Zrsr1mu mice (Figure 1A). We detected the expression of the endogenous ZRSR1
protein at the expected molecular weight in the hypothalamus of WT mice. This band was absent in the
hypothalamus of Zrsr1mu mice, demonstrating the ablation of the wild-type form of ZRSR1. Instead,
we found a weak band with the expected molecular weight for the truncated protein. We conducted a
number of unsuccessful attempts to enrich the truncated protein’s low signal, probably due to its short
half-life, and we corroborated the molecular weight of each band using protein extracts from HEK293
stable cell lines expressing the wild-type or the mutant proteins after induction with tetracycline [1].
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Figure 1. ZRSR1 expression in HEK293 murine cell lines and in mouse hypothalami. Numbers of 
differentially expressed genes (DEG) and differentially expressed isoforms (DEI). Significantly 
enriched Gene Ontology (GO) terms (p < 0.05) in DEGs. (A) Western blot analysis of ZRSR1 protein 
expression. Lanes 1 and 3 correspond to the murine cell lines expressing mZrsr1 and mZrsr1 truncated 
protein, respectively. Expression of ZRSR1 in wild-type (WT) mouse hypothalamus and Zrsr1mu 
mouse hypothalamus is shown in lanes 2 and 4. Actin was used as the loading control (lower panel). 
(B) Venn diagram showing the correspondence between up- and down-regulated genes and isoforms 
in the comparison between Zrsr1mu and WT mouse hypothalami. (C) Significant GO terms in DEGs in 
the pairwise comparison. 
2.2. RNA-seq Analysis of Hypothalami from WT and Zrsr1mu Mice 
To determine the implications of ZRSR1 mutation in the hypothalamus, we performed RNA-seq 
on three WT and three mutant male mouse hypothalamus samples. The RNA-seq database generated 
is available via ArrayExpress (Accesion number E-MTAB-8012). On average, ~120 million 125 bp 
paired-end sequencing reads of each sample aligned uniquely against the mouse reference genome 
(GRCm38/mm10 version) (Supplementary Table 1). After removing genes and transcripts with low 
counts, we evaluated 24,466 genes for differential expression and 97,264 transcripts for differential 
isoform usage. With the DESeq2 R package we obtained a total of 325 genes differentially expressed 
(DEG) (p-value < 0.01) between WT and Zrsr1mu hypothalami (Supplementary Table 2). Out of those 
genes, 228 were down-regulated and 97 were up-regulated in Zrsr1mu. Differentially expressed 
isoforms (DEI) were evaluated with EBSeq software applied to transcript estimated counts obtained 
with RSEM software [23]. DEI analysis showed 534 isoforms (corresponding to 485 genes) that were 
preferentially expressed in the hypothalamus of Zrsr1mu mice, whereas the expression of 608 (522 
genes) isoforms was downregulated in these animals (Supplementary Table 3). A comparison of 
DEGs and DEIs showed that ~57% of the up- and down-regulated genes also had altered expression 
of isoforms (Figure 1B, Supplementary Table 4). Nevertheless, the number of DEIs was ~3.5-fold 
higher than the number of DEGs. This indicates that the effect of the mutation on Zrsr1 has a more 
significant impact on splicing than on transcription. Genes with lower expression in Zrsr1mu were 
Figure 1. ZRSR1 expression in HEK293 murine cell lines and in mouse hypothalami. Numbers
of differentially expres ed ge es (DEG) and differentially expressed isoforms (DEI). Significantly
enriched Gene Ontology (GO) terms (p < 0.05) in DEGs. (A) Western blot analysis of ZRSR1 protein
xpression. Lanes 1 and 3 correspond to the murine cell lines expressing mZrsr1 and m rsr1 truncated
protein, respectively. Expression of ZRSR1 in wild-type (WT) mouse hypothalamus and Zrsr1mu mouse
hypothalamus is shown in lanes 2 and 4. Actin was used as the loading control (lower panel). (B) Venn
diagram showing the correspondenc between up- and down-regulated genes and isoforms in the
comparison between Zrsr1mu and WT mouse hypothalami. (C) Significant GO terms in DEGs in the
pairwise comparison.
2.2. RNA-seq Analysis of Hypothalami from WT and Zrsr1mu Mice
To determine the implications of ZRSR1 mutation in the hypothalamus, we performed RNA-seq
on three WT and three mutant male mouse hypothalamus samples. The RNA-seq database generated
is available via ArrayExpress (Accesion number E-MTAB-8012). On average, ~120 million 125 bp
paired-end sequencing reads of each sample aligned uniquely against the mouse reference genome
(GRCm38/mm10 version) (Supplementary Table S1). After removing genes and transcripts with low
counts, we evaluated 24,466 genes for differential expression and 97,264 transcripts for differential
isoform usage. With the DESeq2 R package we obtained a total of 325 genes differentially expressed
(DEG) (p-value < 0.01) between WT and Zrsr1mu hypothalami (Supplementary Table S2). Out of those
genes, 228 were down-regulated and 97 were up-regulated inZrsr1mu. Differentially expressed isoforms
(DEI) were evaluated with EBSeq software applied to transcript estimated counts obtained with RSEM
software [23]. DEI analysis showed 534 isoforms (corresponding to 485 genes) that were preferentially
expressed in the hypothalamus of Zrsr1mu mice, whereas the expression of 608 (522 genes) isoforms was
downregulated in these animals (Supplementary Table S3). A comparison of DEGs and DEIs showed
that ~57% of the up- and down-regulated genes also had altered expression of isoforms (Figure 1B,
Supplementary Table S4). Nevertheless, the number of DEIs was ~3.5-fold higher than the number of
DEGs. This indicates that the effect of the mutation on Zrsr1 has a more significant impact on splicing
than on transcription. Genes with lower expression in Zrsr1mu were significantly enriched in the
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glutathione metabolic process, apoptotic process, metabolic processes, female pregnancy, and cellular
zinc ion homeostasis Gene Ontology (GO) terms. On the contrary, genes upregulated in Zrsr1mu
hypothalamus showed enrichment in synaptonemal complex assembly, meiotic cell cycle and cell
processes, like cell–cell adhesion, cell chemotaxis, and cell–matrix adhesion GO terms (Figure 1C,
Supplementary Table S5).
Alternative splicing (AS) was assessed using the vast-tools sequence reference, considering a
transcript as differentially spliced when its∆PSI was higher than 0.1. We identified 1283 down-regulated
events and 1776 up-regulated events in the Zrsr1mu hypothalamus, which corresponded to five different
types of splicing—exon skipping (ES), alternative 3′splice site (3′ss), alternative 5′ splice site (5′ss),
intron retention (IR), and microexon (MIC)—keeping only those events identified with high confidence
(Supplementary Table S6, Figure 2A). Enrichment of each event was checked with a Fisher test
comparing them with the total number of each event in the vast-tools database, in relation with the
total number of differentially spliced events detected. All categories of AS being affected, significant
enrichment (p-value < 0.05) was detected for MIC, ES, and IR (Figure 2B, Table 1). As Zrsr1 has been
attributed a role in both U2 and U12 minor splicing, we separated these two intron classes. Out of
665 IR events detected as upregulated in Zrsr1mu, 44 correspond to U12 introns, which represents a
great enrichment when compared with the overall proportion of U12 introns in the mouse genome
(~6.6% against ~0.4%). Moreover, almost 15% of the upregulated IR events occur in U2 introns located
in genes with U12, which agrees with the observations in Zrsr1mu [1] and suggests a communication
between both major and minor spliceosomes. The distribution of U12 and U2 introns located in
U12-containing genes that show an alteration in IR between the hypothalami of Zrsr1mu and WT mice
is shown in Figure 2C.
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Figure 2. RNA-seq analysis of differential alternative splicing (AS) in Zrsr1mu mouse hypothalamus. 
(A) Distribution of the categories of AS events detected in the analysis. 3SS, alternative 3′ splice sites; 
A5SS, alternative 5′ splice sites; ES, exon skipping; IR, intron retention; MIC, alternative microexon. 
(B) Enrichment of the different categories of AS in our analysis in relation with the total number of 
events present in the vast-tools database. (C) Distribution of differentially retained introns that 
correspond to U12 introns (left) and U2 introns located in a U12-intron-containing gene (right) 
Figure 2. RNA-seq analysis of differential alternative splicing (AS) in Zrsr1mu mouse hypothalamus.
(A) Distribution of the categories of AS events detected in the analysis. 3SS, alternative 3′ splice sites;
A5SS, alternative 5′ splice sites; ES, exon skipping; IR, ron retention; MIC, alternative microexon.
(B) Enrichment of the different categories of AS in our analysis in relation with the total number
of events present in the vast-tools database. (C) Distribution of differentially retained introns that
correspond to U12 introns (left) and U2 introns located in a U12-intron-containing gene (right) detected
in our analysis. (D) GO terms associated to biological processes and KEGG pathways enriched in the
U12-containing genes detected as differentially spliced.
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Table 1. Differentially spliced events detected in the Zrsr1mu mice.
Event Type Zrsr1mu Up Zrsr1mu Down Total Events(Vast-Tools)
Enrichment
(p-Value)
3SS 165 186 7048 0.0906
5SS 182 181 7101 0.517
ES 444 346 20,935 2.20 × 10−16
MIC 8 5 643 3.82 × 10−4
IR (U12) 665 (98) 276 (17) 13,903 2.20 × 10−16
Total 1464 994 49,630
Genes that showed IR in genes that contain U12 introns in Zrsr1mu were enriched in mRNA
transport, cilium morphogenesis, protein transport, cyclase activity, DNA repair, and cell functions like
cell project organization, morphogenesis, and the assembly of the nuclear pore complex (Figure 2D,
Supplementary Table S7). This indicates a possible relationship between the defects observed in
Zrsr1mu mice and the mis-regulation of the cell cycle. These genes also showed enrichment in mRNA
transport, the FC epsilon RI signaling pathway, and prolactin, progesterone, and GnRH signaling
pathway-related KEGG pathways (Figure 2D, Supplementary Table S7), suggesting an important role of
Zrsr1 in reproductive control in the hypothalamus. Because the hypothalamus and the pituitary gland
are involved in the regulation of testosterone production by the testes, we analyzed serum testosterone
levels in WT and Zrsr1mu mice, but no differences were observed (5.8 ± 3.9 and 4.7 ± 4.3 ng/mL,
respectively). In addition, the number of Leydig and Sertoli cells was not altered in the testes of mutant
mice, indicating that testosterone levels are not related with the spermatogenesis alterations previously
described in these mutant mice [1].
2.3. Spontaneous and Social Behaviors
Because the hypothalamus is a critical region for the organization of spontaneous, social,
and reproductive behaviors [24], we characterized the behavioral phenotype of Zrsr1mu mice. To this
end we first analyzed spontaneous exploratory behavior in an open field test (Figure 3A,B) and
in an elevated plus maze (Figure 3C). In the open field test, two-way ANOVA revealed that both
Zrsr1mu males and females exhibited a clear hyperactive phenotype, reflected in both the total distance
travelled in the field (Figure 3A, F(1,36) = 19.4, p < 0.001 for genotype, despite females being more
active than males, F(1,36) = 20.8, p < 0.001) and the average speed exhibited (Figure 3B, F(1,36) = 12.6,
p < 0.01 for genotype). This hyperactivity was also observed in the elevated plus maze (data not
shown), where Zrsr1mu mice displayed clear sex-dimorphic responses in the anxiety-associated
responses. Female Zrsr1mu mice showed a marked reduction in the exploration of the open arms of the
maze, indicating an anxiety-like state, whereas the males exhibited an opposite non-significant trend
(Figure 3C, sex × genotype interaction F(1,36) = 4.8, p < 0.04). Female mice were not controlled for
estrous cycle and were randomly cycling, this factor being a potential limitation for the behavioral
performance in this sex.
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Because social interaction in males is often associated with aggressive behavior in male mice, we 
analyzed this pattern of behavior in a social interaction test (Figure 4). Surprisingly, neither wild-type 
nor Zrsr1mu mice displayed aggression, but we found a marked increase of social exploration in 
Zrsr1mu male mice with respect to control wild-type mice (Figure 4D, t = 4.02, df = 17, p < 0.001).  
Figure 3. Performance in the open field test. Panel (A) represents total distance travelled, panel (B)
repr sents average speed of movement of mal and f mal wild-type (co trol) and Zrsr1mu mice.
Panel (C) represents anxiety in the elevated plus aze of male and female wild-type and Zrsr1mu
mice. Data are means ± SEM of at least 8 animals per group. * p < 0.05, ** p < 0.01, **** p < 0.001,
2-way ANOVA.
Because social interaction in males is often associated with aggressive behavior in male mice,
we analyzed this pattern of behavior in a social interaction test (Figure 4). Surprisingly, neither
wild-type nor Zrsr1mu mice displayed aggression, but we found a marked increase of social exploration
in Zrsr1mu male mice with respect to control wild-type mice (Figure 4D, t = 4.02, df = 17, p < 0.001).
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Figure 4. Performance in a social interaction test of male wild-type and Zrsr1mu mice. Panels: (A) body
care activity, (B) exploratory digging, (C) non-social exploration of the field, and (D) time spent in
social exploration. Data are means ± SEM of at least 8 animals per group. *** p < 0.005.
2.4. Cell Proliferation and Survival
The alterations found in the transcription and splicing of genes related to the cell cycle, suggesting
the exist nce of a mi -regulation of the cell cycle, as well as alterations in transcription and/or intron
retention in cell proc ss s, led us to exam ne adult hypothalamic c prolif a d survival in
Zrsr1mu male and female mice. Th results indicate that both male and fe ale Zrsr1mu mice show
decreased cell proliferatio in the subventricular zone (F(1,20) = 23.7, p < 0.0001, Figur 5), but only
females have defective cell prolifera ion in the hypothalamus (F(1,20) = 7.2, p = .014, Figure 6).
Survival of proliferating cells in the subventricular zone w s reduced only in female Zrsr1mu mice
(sex × gen type nteraction, F(1,20) = 4.8, p = 0.039, Figure 5). Overall, Zrsr1mu mice showed consistent
defective cell proliferation in accordance with the alterations in gene tran cription and mRNA spl cing
proc sses described above.
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number of BrdU- and IdU-immunoreactive (+) cells in the subventricular zone (SVZ) of male and 
female wild-type and Zrsr1mu mice. Low- and high-resolution photomicrographs of representative 
images showing BrdU+ cells (C–F) and IdU+ cells (G–J). Arrowheads indicate labeled nuclei. Bars 
represent the mean ± SEM (n = 7–8/group). Tukey (A) or simple effect analysis (B): ∗p < 0.05, ∗∗p < 0.01 
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Figure 5. Newborn cell survival (A) and neural stem cell proliferation (B) respectively assessed by the
number of BrdU- and IdU-immunoreactive (+) cells in the subventricular zone (SVZ) of male and female
wild-type and Zrsr1mu mice. Low- and high-resolution photomicrographs of representative images
showing BrdU+ cells (C–F) and IdU+ cells (G–J). Arrowheads indicate labeled nuclei. Bars represent
the mean ± SEM (n = 7–8/group). Tukey (A) or simple effect analysis (B): * p < 0.05, ** p < 0.01 female
vs. control male and # p < 0.05 ## p < 0.01 wild-type vs. Zrsr1mu. Str, striatum; lv, lateral ventricle.
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one isoform of Nkx2-3 and alterations in IR of Tacc3 and ES of Tacc3, markers of ventromedial 
hypothalamus neurons (VHN); down-regulation of two isoforms of Gfap, a marker of astrocytes; and 
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Figure 6. Newborn cell survival (A) and neural stem cell proliferation (B) respectively assessed by the
number of BrdU- and IdU-immunoreactive (+) cells in the hypothalami of male and female wild-type
and Zrsr1mu mice. Low- and high-resolution photomicrographs of representative images showing
BrdU+ cells (C–F) and IdU+ cells (G–J). Arrowheads indicate labeled nuclei. Bars represent the
mean ± SEM (n = 7–8/group). Tukey (A) or simple effect analysis (B): * p < 0.05 female vs. control male
and # p < 0.05 wild-type vs. Zrsr1mu. ARC, arcuate nucleus; VMH, ventromedial hypothalamus; ME,
median eminence.
3. Discussion
The present results clearly suggest that Zrsr1mu mice have altered transcription/splicing processes
in the hypothalamus and that these alterations are associated with sex-dimorphic behavioral phenotypes
and adult cell proliferation processes in the brain. We performed RNA-seq on the entire hypothalamus,
and this approach may result in the dilution of signals originating from specific cell populations.
Nevertheless, the sensitivity of RNA-seq allows the detection of particular cell-specific markers. In fact,
we could detect alterations of gene expression and AS in known markers of specific hypothalamic cell
populations. Our data showed down-regulation of Foxo3 and ES alteration in Npy, markers for neurons
forming the arcuate nucleus. We also found up-regulation of one isoform of Nkx2-3 and alterations in
IR of Tacc3 and ES of Tacc3, markers of ventromedial hypothalamus neurons (VHN); down-regulation
of two isoforms of Gfap, a marker of astrocytes; and alteration of IR and 3′ss of Lepr, a marker of
multiple hypothalamic cells. However, we did not observe alterations in endothelial-cell-specific
genes. Interestingly, we found down-regulation of two isoforms of hemoglobin subunit alpha 2
(Hba2). Hemogl bin expression has also been observed i several cells, including neurons [25],
and we previously reported that Zrsr1mu mice sh w alterations in erythrocytes [1]. We also f und
down-regulation of Gnrh (g nadotropin-releasing hormone), which is secreted by the medi basal
hypot alamus and is a major lig nd of the male gonadal axis, along with down-r gulation of the
isoform 3 of Fgfr3 (fibroblast growth fact receptor 3) and ES alterati ns of Prok2 (prokineticin 2), two
gen s critical for proper gonadotropin-releasi g hormone (GnRH) neuronal migration nd function [26].
GnRH stimulates gonadotr pins located n the anterior pituitary o secrete luteinizing hormo e (LH)
Int. J. Mol. Sci. 2019, 20, 3543 10 of 18
and follicle-stimulating hormone (FSH). FSH acts on Sertoli cells in spermatogenic tubules and LH
acts on Leydig cells in the testis interstitium. The lower expression of GnRH in Zrsr1mu mice could be
related with their altered spermatogenesis and infertility [1]. In addition, GnRH has been associated
with the regulation of anxiety [26,27] and aggression [28] responses in rodents. GnRH signaling
promotes anxiolysis, antagonizes anxiety and depression induced by corticotrophin-releasing factor,
and suppresses aggression. However, central infusion of GnRH antagonists induced the opposite
pattern of behavior. The behavioral phenotype of Zrsr1mu female mice (anxiety and hyperactivity)
matches that of defective GnRH signaling. However, male mice exhibited an opposite pattern,
with neither aggression nor anxiety and with enhanced social interaction, suggesting that other
alterations in genes related with male social behavior might be affected in Zrsr1mu male mice.
In relation with the friendly, non-aggressive social interaction exhibited by male Zrsr1mu mice,
it has been reported that removing testosterone and estrogens by testiclectomy in male rodents results
in loss of aggression in response to territorial intrusion [29]. However, we did not find alterations in
testosterone levels in Zrsr1mu mice. Although several brain areas have been implicated in aggressive
behavior, little is known about male territorial aggression. The medial hypothalamus is a key component
of the social decision-making network and has a long-established role in inter-male aggression in
vertebrates [30]. The ventrolateral part of the hypothalamus (VMH) can mediate both acute attack
and flexible seeking actions that precede attack (social perception of an opponent) [31]; silencing this
area suppresses naturally occurring inter-male attack, and stimulation promotes attack [31]. Moreover,
the social context exerts a dominant influence on developmentally hard-wired hypothalamus-mediated
male territorial aggression [32]. Estrogen receptor alpha (ERα) levels in several brain areas, such as the
anterior hypothalamus, were shown to be higher in more aggressive mice [33], and reduction of ERα in
the VMH abolished aggressive behavior in males, demonstrating that expression of ERα in the VMH is
necessary for aggression in adult mice [34]. In rodents, aromatase (estrogen synthetase) is expressed
in the axon terminal, particularly in the hypothalamus [35]. However, we did not find differences
in gene or isoform expression of genes related with testosterone or estrogens in the hypothalamus.
There is also a link between glucocorticoids and aggression [36]; prevention of glucocorticoid synthesis
and acute treatment with adenocorticotropic hormone (ACTH) increased fighting behavior in male
mice [36]. We found down-regulation of some isoforms of several genes related with glucocorticoids,
like Sgk3 (serum/glucocorticoid-regulated kinase 3), Crhbp (corticotropin-releasing hormone-binding
protein), and Ucn3 (urocortin 3), in the hypothalamus of Zrsr1mu mice. These genes have been related
with hormonal components of the stress response and aggressive behavior in mice [37]. Notably,
MAP kinase activity has been related with social behavior circuits during resident–intruder aggression
tests [38], and Zrsr1mu hypothalami presented three MAP kinases (Mapk14, Mapk15, and Mapk8) with
U12 intron retention. Remarkably, genomic analyses have shown that minor splicing mechanisms
related with cell differentiation, migration, and neural crest development had a pivotal role in the early
domestication process of dogs [39].
Since the number of U12-type introns is very small, the minor spliceosome has been studied less
extensively than its major counterpart, but in the last few years it has received increasing attention
for its role in neurodevelopmental and neurodegenerative diseases. It has been reported that minor
splicing is crucial for the survival of differentiating neurons [20], and inactivation of minor splicing
in the developing mouse cortex causes self-amplifying radial glial cell death and microcephaly [40].
Our results indicated that Zrsr1 is essential to processing U12-type introns in the hypothalamus, in the
same way as in the testis [1], and that its paralogous Zrsr2 is not able to restore the Zrsr1 functions
in these tissues. These alterations are reflected in the lower rate of cell proliferation in both the
hypothalamus and the subventricular zone in female Zrsr1mu mice, and in the latter area in Zrsr1mu
males. In accordance with the expected survival of differentiating neurons proposed as a result of the
interference with the minor splicing system, female Zrsr1mu animals showed reduced cell survival in
the subventricular zone. Overall, the alterations in cell proliferation and survival might account for the
altered behavioral profile observed in Zrsr1mu mice, since adult neurogenesis (including hypothalamic)
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has been implicated in the organization of multiple behavioral responses, from reproductive behaviors
to social/aggressive interactions [41,42].
A remarkable finding of the present study is the sex-related differences in behavior and brain
cell proliferation patterns that could be related to differences in AS between sexes. A majority of the
mammalian complex traits and disease phenotypes exhibit sex-related differences, but the genetic
mechanisms of such differences have been largely unexplored. AS occurs frequently in the brain and
impacts every step of nervous system development, including neuronal migration, cell-fate decisions,
axon guidance, and synaptogenesis [43]. Sex-specific and lineage-specific changes in the expression of
different splice forms have been reported [44,45]. Sex differences in splicing have been reported in the
human brain [46], and a role has been suggested for sex-biased splicing in disease [46]. The sex-related
alterations in behavior and brain cell proliferation due to the mutation of minor splicing factor ZRSR1
encourage further analyses of the relationship between minor splicing and gender.
4. Materials and Methods
4.1. Animals
The mouse Zrsr1 (NM_011663.3) gene was targeted, and five transgenic lines were successfully
generated [1]. For this study, two lines with 4 and 5 nt deletions were used (Zrsr1 mutant lines 3
and 6). Homozygotes were used in all experiments. Zrsr1mu/+ did not differ phenotypically from
Zrsr1+/+ mice, and both genotypes were used as controls. Line Zrsr1mu3 in homozygosis, which is
the one that presented the greatest alterations in spermatogenesis [1], was the one used for the
Western blots, RNA-seq, and behavioral analysis. Transgenic mice were identified by PCR from tail
DNA with primers 5´ ACGTGCTGCCGGAGTTCAAGAAC and 5´ CCTGCGTACCATCTTCCATT
for amplification of the Zrsr1 WT allele and primers 5´ CCATGACGTGCTGCCGGAGTGAAC and
5´ CCTGCGTACCATCTTCCATT for amplification of the Zrsr1 mutant allele. All animals were of
similar age (5–6 months old) and belonged to the same set of litters. RNA-seq, behavioral studies,
and neurogenesis studies were done in different groups of animals. Animal experiments were
carried out in strict accordance with the recommendations stipulated in the guidelines of European
Community Council Directive 2010/63/EU. Experiments were approved by the Committee on the
Ethics of Animal Experiments of the INIA (permit number CEEA 2012/021). For testosterone analysis,
blood samples were collected from 10 WT and 10 Zrsr1mu mice and were centrifuged for serum
separation, and testosterone levels in serum were determined using an ELISA kit (DRG International,
Inc, Springfiel, NJ, USA) according to the manufacturer´s instructions.
4.2. RNA Extraction and RNA-seq Analysis
Total RNA was extracted from the hypothalami of three wild-type mice and three Zrsr1mu mice at
3 months of age using the TRIzol® reagent (Invitrogen; Carlsbad, CA, USA) and then treated with
DNase (Promega, Alcobendas, Madrid, Spain) for 1 h. RNA-seq libraries were prepared from the
samples described above. The resulting cDNA libraries were used for sequencing using a HiSeq2500
v4 chemistry system at the Centre of Genomic Regulation (Barcelona, Spain). Sequencing yielded
an average of ~65 million of 125 pb paired-end sequences per sample (~130 million sequences per
sample). First, the quality of the sequences was assessed using FastQC (http://www.bioinformatics.
babraham.ac.uk/projects/fastqc/). Then, the sequences were trimmed using Trimmomatic software(http:
//www.usadellab.org/cms/?page=trimmomatic) [47]. Full genomic and transcriptomic sequences of
Musmusculus (version GRCm38/mm10) were downloaded from Ensembl [48]. Each sample was aligned
against the reference genome using STAR [49] with the additional parameters –outSAMstrandField
intronMotif and –quantMode Transcriptome SAM.
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4.3. Differential Gene Expression Analysis
The alignments obtained with STAR were sorted using samtools software [23]. Once sorted,
the matrices with the gene counts were extracted from the aligned reads using HTSeq-count [50] and
joined together into a single matrix with custom scripts for downstream expression analyses. Prior to
the analysis, we discarded the genes with less than two reads in at least three samples. The subsequent
differential gene expression analysis was performed using the DESeq2 v3.20.0 Bioconductor-R package [51],
which performs independent filtering of weakly expressed genes, to improve the sensitivity of differential
expression tests. Genes with adjusted p-values below 0.01 were considered as differentially expressed.
4.4. Differential Isoform Expression Analysis
Raw transcript counts were extracted from the transcriptome alignment files using RSEM software
v3.3.3 (https://deweylab.github.io/RSEM/) [23]. Then, differentially expressed isoforms were calculated
using EBSeq package v3.24.0 [52]. Differential isoform usage between WT mice and Zrsr1mu mice was
considered when their FDR was below 0.01.
4.5. Differential Alternative Splicing Analysis and GO Enrichment Analysis
The levels of inclusion of each transcript needed for differential alternative splicing were
determined using vast-tools (https://github.com/vastgroup/vast-tools), normalizing the distribution of
each AS event by the overall number of that event in the mouse transcriptome (Mm10 annotation).
Then, differentially spliced AS events between the two groups were identified by calculating the
difference in their average inclusion levels (∆PSI), filtering those events with low read coverage.
The ∆PSI values of each event were extracted from the inclusion table using custom scripts,
and those which were higher than 0.1 were considered as differentially spliced. The events were
classified as exon skipping (ES), alternative 3′splice site (3′ss), alternative 5′ splice site (5′ss), intron
retention (IR), and microexon (MIC). Intron retention events which correspond to U12 events were
determined using custom scripts, combining our results with mouse U12 events obtained from U12db
(http://genome.crg.es/cgi-bin/u12db/u12db.cgi), to check the U12 enrichment in the Zrsr1mu mice.
Fisher testing was performed to determine the enrichment of each category in relation to the total
number of events in the vast-tools database.
Gene Ontology enrichment analysis was performed using the David Gene Functional Classification
Tool [53]. Terms with p-values below 0.05 were considered as significantly enriched. All the
bioinformatics and statistical analyses were performed on the Finisterrae server (Supercomputing
Center of Galicia).
4.6. Western Blotting
Samples from the hypothalami of WT and Zrsr1mu mice were lysed in 300µL of RIPA buffer
containing 50 mM TrisHCl pH 7.6, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and 0.1%
SDS supplemented with cOmpleteTM, EDTA-free Protease Inhibitor Cocktail (Roche, Basel, Switzerland)
for 1 h at 4 ◦C. The lysate was centrifuged (12,000g; 15 min) and the supernatant collected for protein
analysis. Total protein was quantified using the PierceTM BCA Protein Assay Kit (TermoFisher
Scientific, Waltham, MA, USA) following the manufacturer’s instructions. Proteins were resolved
by SDS-PAGE (10% of acrylamide loading 50 µg of total protein per well) and transferred onto a
nitrocellulose membrane for immunoblotting following standard procedures. Blocking was conducted
with 3% BSA in PBS-T, and membranes were incubated overnight at 4 ◦C with a rabbit polyclonal
anti-ZRSR1 antibody, generated against KLH-conjugated synthetic peptide #3: CALEAPPEEDDDVSAN
(ChinaPeptides) of the mouse protein (kindly provided by Dr Juan Valcárcel, ICREA and Center
for Genomic Regulation (CRG)). Incubation with the secondary antibody goat anti-rabbit IgG-HRP
(Santa Cruz Biotechnology, Dallas, TX, USA, sc-2004) was conducted for 2 h at room temperature.
The monoclonal anti-β-actin−peroxidase antibody produced in mouse (Merk, Darmstadt, Germany,
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A3854) was used as the loading control, and blocked membranes were incubated at room temperature
for 2 h before development. To develop the plates, we used Amersham ECL Prime Western Blotting
Detection Reagent (GE Healthcare Life Sciences, Buckinghamshire, United Kingdom) following the
manufacturer’s instructions. The chemiluminescent signal was digitalized using an ImageQuant
LAS 500 chemiluminescence CCD camera (GE Healthcare Life Sciences, USA, 29005063). As controls,
we employed two HEK293 stable cell lines expressing mouse Zrsr1 (WT) and mouse Zrsr1 truncated
protein (ZRSR1mu3) when inducing with tetracycline [1]. Protein extraction and Western blotting in
these cell lines were conducted as described for samples from mouse hypothalamus.
4.7. Open Field
All animal studies were done with animals of 5–6 months of age. The testing order was the open
field first, the elevated plus maze second, and the social interaction test third. Animals were left
undisturbed for at least one week between testing procedures. The open field test [54] was performed
in a black wooden box (40 × 40 × 45 cm high), under constant illumination, and the motor activity was
recorded and analyzed using SMART video tracking software (Panlab, Llobregat, Barcelona, Spain).
Animals were placed in the center of the arena and their exploratory activity was monitored for 5 min.
Then, the animal was picked up and the area was cleaned with a 5% ethanol solution.
4.8. Elevated Plus Maze
The elevated plus maze [55] consisted of two opposing open arms, 50 × 10 cm, and two enclosed
arms, 50 × 10 × 40 cm, made of wood, elevated 50 cm above the floor and with the central square
formed by the arms left open. The experiment took place in a sound-isolated room illuminated by a
dim light. The mouse was positioned in the central square, and the event was video recorded and
analyzed using SMART video tracking software (Panlab); after 5 min, the animal was returned to
its home cage and the apparatus was cleaned. The time spent in the open arms of the maze was
considered an index of the animal’s anxiety.
4.9. Social Behavior
The general design of the social interaction test was adapted from [56]. A pair of mice
confronted each other in a familiar area, weakly lit by a red 40 W bulb. The social encounters
were videotaped and posteriorly quantified using JWatcher 1.0 by experienced researchers blind to the
experimental conditions [57]. The following behavioral categories were considered: body care, digging,
nonsocial exploration, exploration from a distance, social investigation, threat, attack, avoidance/flee,
defense/submission, and immobility.
4.10. Proliferation and Survival Analysis in the Hypothalamus and Subventricular Zone
5′-bromo-2′-deoxyuridine (BrdU, cat. no. B5002, Sigma, St. Louis, MO, USA) was dissolved at
15 mg/mL in sterile 0.9% NaCl solution. BrdU was intraperitoneally (i.p.) administered at a dose of
50 mg/kg body weight twice per day for three consecutive days (Days 1–3, 6–8 h between injections).
5′-iodo-2′-deoxyuridine (IdU, cat. no. I7125, Sigma) was also dissolved at 15 mg/mL in sterile 0.9%
NaCl solution. IdU was i.p. administered at a dose of 57.65 mg/kg body weight twice per day for three
consecutive days (Days 17–19, 6–8 h between injections). The animals were killed 12 h after the last
injection of IdU was administered.
4.10.1. Brain Collection
All animals were i.p. anesthetized (sodium pentobarbital, 50 mg/kg body weight) and
transcardially perfused with 4% formaldehyde in 0.1 M phosphate buffer (PB). The brains were dissected
out and kept in the same fixative solution overnight at 4 ◦C. The brains were then cryoprotected and
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cut into 30 µm thick coronal sections by using a sliding microtome (Leica VT1000S). Sections were
divided into five parallel series until use for immunohistochemistry.
4.10.2. Immunohistochemistry
Free-floating coronal sections from −1.58 to −2.46 mm Bregma levels (hippocampus and
hypothalamus) and 1.42 to −0.10 mm Bregma levels (striatum) from one of the five parallel series
obtained from each mouse brain were selected for each immunohistochemistry analysis (Mouse
Atlas, [58]). Sections were first washed several times with PBS to remove sodium azide. Then, sections
were incubated in a solution of 3% hydrogen peroxide and 10% methanol in PB 0.1 M for 45 min at room
temperature in darkness to inactivate endogenous peroxidase. After three washes in PBS for 10 min,
DNA was denatured by exposing sections to HCl 2 N for 15 min at 37 ◦C, followed by two washes in
borate buffer 0.15 M to neutralize pH. After three additional washes in PBS for 10 min, sections were
incubated in a blocking solution containing 10% donkey serum, 0.3% Triton X-100, and 0.05% sodium
azide in PBS for 45 min. Sections were incubated overnight in the primary antibody rat anti-BrdU
(1:500; Accurate Chemical & Scientific, Westbury, NY, USA, cat. no. OBT0030G) at 4 ◦C. For IdU
immunohistochemistry, brain sections were firstly incubated in a solution of 3% hydrogen peroxide
and 10% methanol in PB 0.1 M for 10 min; secondly incubated in a blocking solution containing 5%
goat serum, 0.3% Triton X-100, and 0.05% sodium azide in PBS for 1 h; and finally incubated overnight
in the primary antibody mouse anti-IdU (1:500; Rockland, Gilbertville, PA, USA, cat. no. 200-301-H51)
at room temperature. The following day the sections were incubated in the biotinylated donkey
anti-rat IgG (H+L) antibody (1:500, Novex; cat. no. A18743) or the biotinylated goat anti-mouse IgG
antibody (1:1000, Sigma; cat. no. B7254) for 90 min. The sections were then incubated in ExtrAvidin
peroxidase (Sigma, St. Louis, MO, USA) diluted 1:2000 in darkness at room temperature for 1 h. Finally,
immunolabeling was revealed with 0.05% diaminobenzidine (DAB; Sigma) and 0.03% H2O2 in PBS.
4.10.3. Quantification of BrdU- and IdU-Immunoreactive Cells
The average density of positive cells per animal was quantified. Thus, the estimation of the number
of cells per section (30 µm deep) in both hemispheres was calculated. Each structure analyzed consisted
of ~6 coronal sections, which resulted in one of every five equidistant sections (one representative
section for each 180 µm) according to the rostro-caudal extent. To outline the area of study, the region
of interest was drawn in each structure, the identification of which was performed at Bregma −1.58 to
−2.46 mm in hippocampal and hypothalamic levels and at Bregma 1.42 to −0.10 mm in striatal levels
according to a mouse brain atlas and cytoarchitectonic criteria [58]. Thus, the BrdU-immunoreactive
(+) nuclei and IdU-immunoreactive (+) nuclei that came into focus were manually counted in the
hypothalamus and the subventricular zone (SVZ) of the lateral ventricles. Regarding the hypothalamus,
counting was performed in the ventromedial (VMH) and arcuate (ARC) nuclei of the hypothalamus
and median eminence. Quantification was performed using a standard optical microscope with 40×
objective (Nikon Instruments Europe B.V., Amstelveen, The Netherlands) coupled to NIS-Elements
Imaging Software 3.00 (Nikon). The data were expressed as the number of positive cells per section.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/14/
3543/s1. Supplementary Table S1. Summary of RNA-seq alignment; Supplementary Table S2. Differentially
expressed genes in Zrsr1mu and WT mouse hypothalami; Supplementary Table S3. Differentially expressed
isoforms in Zrsr1mu and WT mouse hypothalami; Supplementary Table S4. List of common up-regulated and
down-regulated genes and isoforms; Supplementary Table S5. Gene Ontology analysis of up- and down-regulated
genes in Zrsr1mu hypothalamus; Supplementary Table S6. List of alternative splicing events in Zrsr1mu and WT
mouse hypothalami; Supplementary Table S7. Gene Ontology analysis of preferentially retained U12 introns in
Zrsr1mu vs. WT mouse hypothalami.
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